About: Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Latest price: $9.08 (-5.22%)
PTN NASDAQ Palatin Technologies, Inc. Common Stock
Palatin Technologies, Inc. Common Stock share price
PTN price activity
Last Price
$9.080
Change (24hr)
-0.50 USD (-5.22%)
Volume
19.41K
Volume (4w avg)
-
Open
$9.54
Day Range
$9.04 - $9.58
Previous Close
$9.58
Last Trade
29 Sep, 5:42 pm GMT+0
Delayed
29 Sep, 5:42 pm GMT+0
PTN price performance
Delayed
29 Sep, 5:42 pm GMT+0
PTN Market Signals